Diagnostic Performance of F18-FDG PET/CT in Male Breast Cancers Patients.

Andra Mester Doina PiciuNarcis PolocoserAnita A KovendiIulia AlmasanAlexandru MesterDragos-Stefan MorariuCalin Ioan CăinapSimona Sorana Cainap

Published in: Diagnostics (Basel, Switzerland) (2021)

F18-FDG PET/CT is a valuable tool to provide information on extra-axillary lymph node involvement, distant metastases, and other occult primary cancers. Baseline F18-FDG PET/CT has a substantial impact on the initial staging and on clinical management in male breast patients and should be considered for use in newly diagnosed patients.

Keyphrases

newly diagnosed
lymph node
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
young adults
patient reported outcomes
radiation therapy
neoadjuvant chemotherapy
rectal cancer